{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:14:43Z","timestamp":1776356083980,"version":"3.51.2"},"reference-count":118,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Influenza is a seasonal disease that affects millions of people every year and\nhas a significant economic impact. Vaccines are the best strategy to fight this viral pathology, but they\nare not always available or administrable, prompting the search for antiviral drugs. RNA-dependent\nRNA polymerase (RdRp) recently emerged as a promising target because of its key role in viral replication\nand its high conservation among viral strains.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Discussion:<\/jats:title>\n<jats:p>This review presents an overview of the most interesting RdRp inhibitors that have been\ndiscussed in the literature since 2000. Compounds already approved or in clinical trials and a selection\nof inhibitors endowed with different scaffolds are described, along with the main features responsible\nfor their activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>RdRp inhibitors are emerging as a new strategy to fight viral infections and the importance\nof this class of drugs has been confirmed by the FDA approval of baloxavir marboxil in 2018. Despite\nthe complexity of the RdRp machine makes the identification of new compounds a challenging research\ntopic, it is likely that in the coming years, this field will attract the interest of a number of academic\nand industrial scientists because of the potential strength of this therapeutic approach.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867327666200114115632","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T13:14:14Z","timestamp":1579007654000},"page":"1068-1090","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus Agents"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2920-3402","authenticated-orcid":true,"given":"Ilaria","family":"Giacchello","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7228-0086","authenticated-orcid":true,"given":"Francesca","family":"Musumeci","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-7326","authenticated-orcid":true,"given":"Ilaria","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1773-584X","authenticated-orcid":true,"given":"Chiara","family":"Greco","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-004X","authenticated-orcid":true,"given":"Giancarlo","family":"Grossi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-786X","authenticated-orcid":true,"given":"Silvia","family":"Schenone","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e00031","DOI":"10.1128\/mBio.00031-14","volume":"5","author":"Hause B.M.","year":"2014","unstructured":"Hause B.M.; Collin E.A.; Liu R.; Huang B.; Sheng Z.; Lu W.; Wang D.; Nelson E.A.; Li F.; Characterization of a novel influenza virus in cattle and swine: proposal for a new genus in the Orthomyxoviridae family. MBio 2014,5(2),e00031-e14","journal-title":"MBio"},{"key":"ref=2","author":"Couch R.B.","unstructured":"Couch R.B.; Orthomyxoviruses. In Chapter 58: Medical\nMicrobiology, 4th ed.; Baron, S., Ed.; University of Texas\nMedical Branch at Galveston: Galveston (TX), 1996."},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/irv.12412","volume":"11","author":"Joseph U.","year":"2017","unstructured":"Joseph U.; Su Y.C.F.; Vijaykrishna D.; Smith G.J.D.; The ecology and adaptive evolution of influenza A interspecies transmission. Influenza Other Respir Viruses 2017,11(1),74-84","journal-title":"Influenza Other Respir Viruses"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/med.21401","volume":"36","author":"Stevaert A.","year":"2016","unstructured":"Stevaert A.; Naesens L.; The influenza virus polymerase complex: an update on its structure, functions, and significance for antiviral drug design. Med Res Rev 2016,36(6),1127-1173","journal-title":"Med Res Rev"},{"key":"ref=5","author":"Boktor S.W.","unstructured":"Boktor S.W.; Hafner J.W.; Influenza. In; StatPearls [internet], StatPearls Publishing, Treasure Island, Florida, 2021."},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1073\/pnas.73.6.2142","volume":"73","author":"Palese P.","year":"1976","unstructured":"Palese P.; Schulman J.L.; Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes. Proc Natl Acad Sci USA 1976,73(6),2142-2146","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1128\/JVI.20.1.307-313.1976","volume":"20","author":"Ritchey M.B.","year":"1976","unstructured":"Ritchey M.B.; Palese P.; Schulman J.L.; Mapping of the influenza virus genome. III. Identification of genes coding for nucleoprotein, membrane protein, and nonstructural protein. J Virol 1976,20(1),307-313","journal-title":"J Virol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nm1201-1306","volume":"7","author":"Chen W.","year":"2001","unstructured":"Chen W.; Calvo P.A.; Malide D.; Gibbs J.; Schubert U.; Bacik I.; Basta S.; O\u2019Neill R.; Schickli J.; Palese P.; Henklein P.; Bennink J.R.; Yewdell J.W.; A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001,7(12),1306-1312","journal-title":"Nat Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1128\/JVI.00826-09","volume":"83","author":"Wise H.M.","year":"2009","unstructured":"Wise H.M.; Foeglein A.; Sun J.; Dalton R.M.; Patel S.; Howard W.; Anderson E.C.; Barclay W.S.; Digard P.; A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 2009,83(16),8021-8031","journal-title":"J Virol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1126\/science.1222213","volume":"337","author":"Jagger B.W.","year":"2012","unstructured":"Jagger B.W.; Wise H.M.; Kash J.C.; Walters K-A.; Wills N.M.; Xiao Y-L.; Dunfee R.L.; Schwartzman L.M.; Ozinsky A.; Bell G.L.; Dalton R.M.; Lo A.; Efstathiou S.; Atkins J.F.; Firth A.E.; Taubenberger J.K.; Digard P.; An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 2012,337(6091),199-204","journal-title":"Science"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002998","volume":"8","author":"Wise H.M.","year":"2012","unstructured":"Wise H.M.; Hutchinson E.C.; Jagger B.W.; Stuart A.D.; Kang Z.H.; Robb N.; Schwartzman L.M.; Kash J.C.; Fodor E.; Firth A.E.; Gog J.R.; Taubenberger J.K.; Digard P.; Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog 2012,8(11)","journal-title":"PLoS Pathog"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2012.38","volume":"1","author":"Selman M.","year":"2012","unstructured":"Selman M.; Dankar S.K.; Forbes N.E.; Jia J-J.; Brown E.G.; Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing. Emerg Microbes Infect 2012,1(11)","journal-title":"Emerg Microbes Infect"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1128\/JVI.02656-12","volume":"87","author":"Muramoto Y.","year":"2013","unstructured":"Muramoto Y.; Noda T.; Kawakami E.; Akkina R.; Kawaoka Y.; Identification of novel influenza A virus proteins translated from PA mRNA. J Virol 2013,87(5),2455-2462","journal-title":"J Virol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1128\/JVI.02175-15","volume":"90","author":"Yamayoshi S.","year":"2015","unstructured":"Yamayoshi S.; Watanabe M.; Goto H.; Kawaoka Y.; Identification of a novel viral protein expressed from the PB2 segment of influenza A Virus. J Virol 2015,90(1),444-456","journal-title":"J Virol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00705-018-3708-y","volume":"163","author":"Kumar B.","year":"2018","unstructured":"Kumar B.; Asha K.; Khanna M.; Ronsard L.; Meseko C.A.; Sanicas M.; The emerging influenza virus threat: status and new prospects for its therapy and control. Arch Virol 2018,163(4),831-844","journal-title":"Arch Virol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1021\/cb400400j","volume":"8","author":"Bauman J.D.","year":"2013","unstructured":"Bauman J.D.; Patel D.; Baker S.F.; Vijayan R.S.K.; Xiang A.; Parhi A.K.; Mart\u00ednez-Sobrido L.; LaVoie E.J.; Das K.; Arnold E.; Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors. ACS Chem Biol 2013,8(11),2501-2508","journal-title":"ACS Chem Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virusres.2017.01.013","volume":"234","author":"Pflug A.","year":"2017","unstructured":"Pflug A.; Lukarska M.; Resa-Infante P.; Reich S.; Cusack S.; Structural insights into RNA synthesis by the influenza virus transcription-replication machine. Virus Res 2017,234,103-117","journal-title":"Virus Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.drudis.2018.01.028","volume":"23","author":"Zhou Z.","year":"2018","unstructured":"Zhou Z.; Liu T.; Zhang J.; Zhan P.; Liu X.; Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics. Drug Discov Today 2018,23(3),503-518","journal-title":"Drug Discov Today"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/j.1460-2075.1986.tb04506.x","volume":"5","author":"Jones I.M.","year":"1986","unstructured":"Jones I.M.; Reay P.A.; Philpott K.L.; Nuclear location of all three influenza polymerase proteins and a nuclear signal in polymerase PB2. EMBO J 1986,5(9),2371-2376","journal-title":"EMBO J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1128\/JVI.61.7.2217-2224.1987","volume":"61","author":"Akkina R.K.","year":"1987","unstructured":"Akkina R.K.; Chambers T.M.; Londo D.R.; Nayak D.P.; Intracellular localization of the viral polymerase proteins in cells infected with influenza virus and cells expressing PB1 protein from cloned cDNA. J Virol 1987,61(7),2217-2224","journal-title":"J Virol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0042-6822(87)90004-3","volume":"160","author":"Smith G.L.","year":"1987","unstructured":"Smith G.L.; Levin J.Z.; Palese P.; Moss B.; Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 1987,160(2),336-345","journal-title":"Virology"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1128\/MCB.10.8.4139","volume":"10","author":"Nath S.T.","year":"1990","unstructured":"Nath S.T.; Nayak D.P.; Function of two discrete regions is required for nuclear localization of polymerase basic protein 1 of A\/WSN\/33 influenza virus (H1 N1). Mol Cell Biol 1990,10(8),4139-4145","journal-title":"Mol Cell Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1128\/JVI.65.1.245-253.1991","volume":"65","author":"Mukaigawa J.","year":"1991","unstructured":"Mukaigawa J.; Nayak D.P.; Two signals mediate nuclear localization of influenza virus (A\/WSN\/33) polymerase basic protein 2. J Virol 1991,65(1),245-253","journal-title":"J Virol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0168-1702(92)90031-4","volume":"24","author":"Nieto A.","year":"1992","unstructured":"Nieto A.; de la Luna S.; B\u00e1rcena J.; Portela A.; Valc\u00e1rcel J.; Melero J.A.; Ort\u00edn J.; Nuclear transport of influenza virus polymerase PA protein. Virus Res 1992,24(1),65-75","journal-title":"Virus Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1099\/0022-1317-75-1-29","volume":"75","author":"Nieto A.","year":"1994","unstructured":"Nieto A.; de la Luna S.; B\u00e1rcena J.; Portela A.; Ort\u00edn J.; Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit. J Gen Virol 1994,75(Pt 1),29-36","journal-title":"J Gen Virol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"9144","DOI":"10.1128\/JVI.78.17.9144-9153.2004","volume":"78","author":"Fodor E.","year":"2004","unstructured":"Fodor E.; Smith M.; The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. J Virol 2004,78(17),9144-9153","journal-title":"J Virol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1128\/JVI.01917-06","volume":"81","author":"Naito T.","year":"2007","unstructured":"Naito T.; Momose F.; Kawaguchi A.; Nagata K.; Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J Virol 2007,81(3),1339-1349","journal-title":"J Virol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/0042-6822(89)90615-6","volume":"171","author":"Yamashita M.","year":"1989","unstructured":"Yamashita M.; Krystal M.; Palese P.; Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Virology 1989,171(2),458-466","journal-title":"Virology"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature14008","volume":"516","author":"Pflug A.","year":"2014","unstructured":"Pflug A.; Guilligay D.; Reich S.; Cusack S.; Structure of influenza A polymerase bound to the viral RNA promoter. Nature 2014,516(7531),355-360","journal-title":"Nature"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1042\/BST0381598","volume":"38","author":"Cowling V.H.","year":"2010","unstructured":"Cowling V.H.; Myc up-regulates formation of the mRNA methyl cap. Biochem Soc Trans 2010,38(6),1598-1601","journal-title":"Biochem Soc Trans"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nature07745","volume":"458","author":"Dias A.","year":"2009","unstructured":"Dias A.; Bouvier D.; Cr\u00e9pin T.; McCarthy A.A.; Hart D.J.; Baudin F.; Cusack S.; Ruigrok R.W.H.; The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009,458(7240),914-918","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/nar\/gkx1210","volume":"46","author":"Pflug A.","year":"2018","unstructured":"Pflug A.; Gaudon S.; Resa-Infante P.; Lethier M.; Reich S.; Schulze W.M.; Cusack S.; Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors. Nucleic Acids Res 2018,46(2),956-971","journal-title":"Nucleic Acids Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nature07720","volume":"458","author":"Yuan P.","year":"2009","unstructured":"Yuan P.; Bartlam M.; Lou Z.; Chen S.; Zhou J.; He X.; Lv Z.; Ge R.; Li X.; Deng T.; Fodor E.; Rao Z.; Liu Y.; Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 2009,458(7240),909-913","journal-title":"Nature"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002830","volume":"8","author":"DuBois R.M.","year":"2012","unstructured":"DuBois R.M.; Slavish P.J.; Baughman B.M.; Yun M-K.; Bao J.; Webby R.J.; Webb T.R.; White S.W.; Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease. PLoS Pathog 2012,8(8)","journal-title":"PLoS Pathog"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1128\/JVI.00600-06","volume":"80","author":"Hara K.","year":"2006","unstructured":"Hara K.; Schmidt F.I.; Crow M.; Brownlee G.G.; Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding. J Virol 2006,80(16),7789-7798","journal-title":"J Virol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1021\/bi9828932","volume":"38","author":"Doan L.","year":"1999","unstructured":"Doan L.; Handa B.; Roberts N.A.; Klumpp K.; Metal ion catalysis of RNA cleavage by the influenza virus endonuclease. Biochemistry 1999,38(17),5612-5619","journal-title":"Biochemistry"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1073\/pnas.90.14.6498","volume":"90","author":"Steitz T.A.","year":"1993","unstructured":"Steitz T.A.; Steitz J.A.; A general two-metal-ion mechanism for catalytic RNA. Proc Natl Acad Sci USA 1993,90(14),6498-6502","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0959-440X(02)00324-X","volume":"12","author":"Fedor M.J.","year":"2002","unstructured":"Fedor M.J.; The role of metal ions in RNA catalysis. Curr Opin Struct Biol 2002,12(3),289-295","journal-title":"Curr Opin Struct Biol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1021\/ar500314j","volume":"48","author":"Palermo G.","year":"2015","unstructured":"Palermo G.; Cavalli A.; Klein M.L.; Alfonso-Prieto M.; Dal Peraro M.; De Vivo M.; Catalytic metal ions and enzymatic processing of DNA and RNA. Acc Chem Res 2015,48(2),220-228","journal-title":"Acc Chem Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1002\/j.1460-2075.1989.tb08565.x","volume":"8","author":"Poch O.","year":"1989","unstructured":"Poch O.; Sauvaget I.; Delarue M.; Tordo N.; Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J 1989,8(12),3867-3874","journal-title":"EMBO J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1128\/JVI.68.3.1819-1826.1994","volume":"68","author":"Biswas S.K.","year":"1994","unstructured":"Biswas S.K.; Nayak D.P.; Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1. J Virol 1994,68(3),1819-1826","journal-title":"J Virol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nsmb1212","volume":"14","author":"Tarendeau F.","year":"2007","unstructured":"Tarendeau F.; Boudet J.; Guilligay D.; Mas P.J.; Bougault C.M.; Boulo S.; Baudin F.; Ruigrok R.W.H.; Daigle N.; Ellenberg J.; Cusack S.; Simorre J.P.; Hart D.J.; Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat Struct Mol Biol 2007,14(3),229-233","journal-title":"Nat Struct Mol Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nsmb.1421","volume":"15","author":"Guilligay D.","year":"2008","unstructured":"Guilligay D.; Tarendeau F.; Resa-Infante P.; Coloma R.; Crepin T.; Sehr P.; Lewis J.; Ruigrok R.W.H.; Ortin J.; Hart D.J.; Cusack S.; The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol 2008,15(5),500-506","journal-title":"Nat Struct Mol Biol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.virol.2003.11.030","volume":"320","author":"Shinya K.","year":"2004","unstructured":"Shinya K.; Hamm S.; Hatta M.; Ito H.; Ito T.; Kawaoka Y.; PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 2004,320(2),258-266","journal-title":"Virology"},{"key":"ref=45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000252","volume":"5","author":"Steel J.","year":"2009","unstructured":"Steel J.; Lowen A.C.; Mubareka S.; Palese P.; Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E\/701N. PLoS Pathog 2009,5(1)","journal-title":"PLoS Pathog"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"34504","DOI":"10.1074\/jbc.M111.262048","volume":"286","author":"Aggarwal S.","year":"2011","unstructured":"Aggarwal S.; Dewhurst S.; Takimoto T.; Kim B.; Biochemical impact of the host adaptation-associated PB2 E627K mutation on the temperature-dependent RNA synthesis kinetics of influenza A virus polymerase complex. J Biol Chem 2011,286(40),34504-34513","journal-title":"J Biol Chem"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036415","volume":"7","author":"Ng A.K.","year":"2012","unstructured":"Ng A.K.; Chan W.H.; Choi S.T.; Lam M.K.; Lau K.F.; Chan P.K.; Au S.W.; Fodor E.; Shaw P.C.; Influenza polymerase activity correlates with the strength of interaction between nucleoprotein and PB2 through the host-specific residue K\/E627. PLoS One 2012,7(5)","journal-title":"PLoS One"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40265-018-0899-1","volume":"78","author":"Heo Y-A.","year":"2018","unstructured":"Heo Y-A.; Baloxavir: first global approval. Drugs 2018,78(6),693-697","journal-title":"Drugs"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.xphs.2018.12.005","volume":"108","author":"Koshimichi H.","year":"2019","unstructured":"Koshimichi H.; Tsuda Y.; Ishibashi T.; Wajima T.; Population pharmacokinetic and exposure-response analyses of Baloxavir Marboxil in adults and adolescents including patients with influenza. J Pharm Sci 2019,108(5),1896-1904","journal-title":"J Pharm Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","volume":"8","author":"Omoto S.","year":"2018","unstructured":"Omoto S.; Speranzini V.; Hashimoto T.; Noshi T.; Yamaguchi H.; Kawai M.; Kawaguchi K.; Uehara T.; Shishido T.; Naito A.; Cusack S.; Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Sci Rep 2018,8(1),9633","journal-title":"Sci Rep"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.antiviral.2018.10.008","volume":"160","author":"Noshi T.","year":"2018","unstructured":"Noshi T.; Kitano M.; Taniguchi K.; Yamamoto A.; Omoto S.; Baba K.; Hashimoto T.; Ishida K.; Kushima Y.; Hattori K.; Kawai M.; Yoshida R.; Kobayashi M.; Yoshinaga T.; Sato A.; Okamatsu M.; Sakoda Y.; Kida H.; Shishido T.; Naito A.; In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit. Antiviral Res 2018,160,109-117","journal-title":"Antiviral Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"S734","DOI":"10.1093\/ofid\/ofx180.001","volume":"4","author":"Portsmouth S.","year":"2017","unstructured":"Portsmouth S.; Kawaguchi K.; Arai M.; Tsuchiya K.; Uehara T.; Cap-dependent endonuclease inhibitor s-033188 for the treatment of influenza: results from a phase 3, randomized, double-blind, placebo- and active-controlled study in otherwise healthy adolescents and adults with seasonal influenza. Open Forum Infect Dis 2017,4(Suppl. 1),S734","journal-title":"Open Forum Infect Dis"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"Hayden F.G.","year":"2018","unstructured":"Hayden F.G.; Sugaya N.; Hirotsu N.; Lee N.; de Jong M.D.; Hurt A.C.; Ishida T.; Sekino H.; Yamada K.; Portsmouth S.; Kawaguchi K.; Shishido T.; Arai M.; Tsuchiya K.; Uehara T.; Watanabe A.; Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med 2018,379(10),913-923","journal-title":"N Engl J Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/cid\/ciz908","volume":"71","author":"Hirotsu N.","year":"2020","unstructured":"Hirotsu N.; Sakaguchi H.; Sato C.; Ishibashi T.; Baba K.; Omoto S.; Shishido T.; Tsuchiya K.; Hayden F.G.; Uehara T.; Watanabe A.; Baloxavir marboxil in Japanese pediatric patients with influenza: safety and clinical and virologic outcomes. Clin Infect Dis 2020,71(4),971-981","journal-title":"Clin Infect Dis"},{"key":"ref=55","unstructured":"9 Studies found for baloxavir marboxil. U.S. National Library of MedicineAvailable at:\n(Accessed on Feb 15, 2019)"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/infdis\/jiy410","volume":"219","author":"Yogaratnam J.","year":"2019","unstructured":"Yogaratnam J.; Rito J.; Kakuda T.N.; Fennema H.; Gupta K.; Jekle C.A.; Mitchell T.; Boyce M.; Sahgal O.; Balaratnam G.; Chanda S.; Van Remoortere P.; Symons J.A.; Fry J.; Antiviral activity, safety, and pharmacokinetics of AL-794, a novel oral influenza endonuclease inhibitor: results of an influenza human challenge study. J Infect Dis 2019,219(2),177-185","journal-title":"J Infect Dis"},{"key":"ref=57","unstructured":"4 Studies found for: AL-794. U.S. National Library of MedicineAvailable at:\n\n(Accessed on Feb 7, 2019)."},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/0006-291X(79)91853-9","volume":"89","author":"Goswami B.B.","year":"1979","unstructured":"Goswami B.B.; Borek E.; Sharma O.K.; Fujitaki J.; Smith R.A.; The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem Biophys Res Commun 1979,89(3),830-836","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1128\/AAC.01156-16","volume":"60","author":"Vanderlinden E.","year":"2016","unstructured":"Vanderlinden E.; Vrancken B.; Van Houdt J.; Rajwanshi V.K.; Gillemot S.; Andrei G.; Lemey P.; Naesens L.; Distinct effects of T-705 (favipiravir) and ribavirin on influenza virus replication and viral RNA synthesis. Antimicrob Agents Chemother 2016,60(11),6679-6691","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.antiviral.2005.06.003","volume":"68","author":"Sidwell R.W.","year":"2005","unstructured":"Sidwell R.W.; Bailey K.W.; Wong M.H.; Barnard D.L.; Smee D.F.; In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Res 2005,68(1),10-17","journal-title":"Antiviral Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S1473-3099(17)30476-0","volume":"17","author":"Beigel J.H.","year":"2017","unstructured":"Beigel J.H.; Bao Y.; Beeler J.; Manosuthi W.; Slandzicki A.; Dar S.M.; Panuto J.; Beasley R.L.; Perez-Patrigeon S.; Suwanpimolkul G.; Losso M.H.; McClure N.; Bozzolo D.R.; Myers C.; Holley H.P.; Hoopes J.; Lane H.C.; Hughes M.D.; Davey R.T.; Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Lancet Infect Dis 2017,17(12),1255-1265","journal-title":"Lancet Infect Dis"},{"key":"ref=62","unstructured":"Comparing the efficacy,\nsafety, and tolerability of combination antivirals\n(amantadine, ribavirin, oseltamivir) versus oseltamivir for\nthe treatment of influenza in adults at risk for complications. U.S. National Library of MedicineAvailable at:\n\n(Accessed on Feb 1, 2019)"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","volume":"100","author":"Furuta Y.","year":"2013","unstructured":"Furuta Y.; Gowen B.B.; Takahashi K.; Shiraki K.; Smee D.F.; Barnard D.L.; Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 2013,100(2),446-454","journal-title":"Antiviral Res"},{"key":"ref=64","unstructured":"44 Studies found for: favipiravir. U.S. National Library of MedicineAvailable at:\n(Accessed on Feb 1, 2019)."},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1021\/jm5007275","volume":"57","author":"Clark M.P.","year":"2014","unstructured":"Clark M.P.; Ledeboer M.W.; Davies I.; Byrn R.A.; Jones S.M.; Perola E.; Tsai A.; Jacobs M.; Nti-Addae K.; Bandarage U.K.; Boyd M.J.; Bethiel R.S.; Court J.J.; Deng H.; Duffy J.P.; Dorsch W.A.; Farmer L.J.; Gao H.; Gu W.; Jackson K.; Jacobs D.H.; Kennedy J.M.; Ledford B.; Liang J.; Maltais F.; Murcko M.; Wang T.; Wannamaker M.W.; Bennett H.B.; Leeman J.R.; McNeil C.; Taylor W.P.; Memmott C.; Jiang M.; Rijnbrand R.; Bral C.; Germann U.; Nezami A.; Zhang Y.; Salituro F.G.; Bennani Y.L.; Charifson P.S.; Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. J Med Chem 2014,57(15),6668-6678","journal-title":"J Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1128\/AAC.00781-15","volume":"59","author":"Tsai A.W.","year":"2015","unstructured":"Tsai A.W.; McNeil C.F.; Leeman J.R.; Bennett H.B.; Nti-Addae K.; Huang C.; Germann U.A.; Byrn R.A.; Berlioz-Seux F.; Rijnbrand R.; Clark M.P.; Charifson P.S.; Jones S.M.; Novel ranking system for identifying efficacious anti-influenza virus PB2 inhibitors. Antimicrob Agents Chemother 2015,59(10),6007-6016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2016.07.008","volume":"133","author":"Fu Y.","year":"2016","unstructured":"Fu Y.; Gaelings L.; S\u00f6derholm S.; Belanov S.; Nandania J.; Nyman T.A.; Matikainen S.; Anders S.; Velagapudi V.; Kainov D.E.; JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses. Antiviral Res 2016,133,23-31","journal-title":"Antiviral Res"},{"key":"ref=68","unstructured":"4 Studies found for: VX-787.  U.S. National Library of MedicineAvailable at:\n\nAccessed on Feb 1, 2019)."},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1128\/AAC.04623-14","volume":"59","author":"Byrn R.A.","year":"2015","unstructured":"Byrn R.A.; Jones S.M.; Bennett H.B.; Bral C.; Clark M.P.; Jacobs M.D.; Kwong A.D.; Ledeboer M.W.; Leeman J.R.; McNeil C.F.; Murcko M.A.; Nezami A.; Perola E.; Rijnbrand R.; Saxena K.; Tsai A.W.; Zhou Y.; Charifson P.S.; Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit. Antimicrob Agents Chemother 2015,59(3),1569-1582","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.coph.2016.08.003","volume":"30","author":"Naesens L.","year":"2016","unstructured":"Naesens L.; Stevaert A.; Vanderlinden E.; Antiviral therapies on the horizon for influenza. Curr Opin Pharmacol 2016,30,106-115","journal-title":"Curr Opin Pharmacol"},{"key":"ref=71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019825","volume":"6","author":"Iwai Y.","year":"2011","unstructured":"Iwai Y.; Murakami K.; Gomi Y.; Hashimoto T.; Asakawa Y.; Okuno Y.; Ishikawa T.; Hatakeyama D.; Echigo N.; Kuzuhara T.; Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts. PLoS One 2011,6(5)","journal-title":"PLoS One"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0166-3542(93)90008-7","volume":"21","author":"Nakayama M.","year":"1993","unstructured":"Nakayama M.; Suzuki K.; Toda M.; Okubo S.; Hara Y.; Shimamura T.; Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res 1993,21(4),289-299","journal-title":"Antiviral Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1348-0421.2002.tb02724.x","volume":"46","author":"Imanishi N.","year":"2002","unstructured":"Imanishi N.; Tuji Y.; Katada Y.; Maruhashi M.; Konosu S.; Mantani N.; Terasawa K.; Ochiai H.; Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol Immunol 2002,46(7),491-494","journal-title":"Microbiol Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","volume":"68","author":"Song J.M.","year":"2005","unstructured":"Song J.M.; Lee K.H.; Seong B.L.; Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 2005,68(2),66-74","journal-title":"Antiviral Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/aps.2012.80","volume":"33","author":"Ling J.X.","year":"2012","unstructured":"Ling J.X.; Wei F.; Li N.; Li J.L.; Chen L.J.; Liu Y.Y.; Luo F.; Xiong H.R.; Hou W.; Yang Z.Q.; Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea. Acta Pharmacol Sin 2012,33(12),1533-1541","journal-title":"Acta Pharmacol Sin"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1371\/currents.rrn1052]","volume":"1","author":"Kuzuhara T.","year":"2009","unstructured":"Kuzuhara T.; Iwai Y.; Takahashi H.; Hatakeyama D.; Echigo N.; Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase. PLoS Curr 2009,1","journal-title":"PLoS Curr"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002831","volume":"8","author":"Kowalinski E.","year":"2012","unstructured":"Kowalinski E.; Zubieta C.; Wolkerstorfer A.; Szolar O.H.J.; Ruigrok R.W.H.; Cusack S.; Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase. PLoS Pathog 2012,8(8)","journal-title":"PLoS Pathog"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/ml4003474","volume":"5","author":"Chen E.","year":"2014","unstructured":"Chen E.; Swift R.V.; Alderson N.; Feher V.A.; Feng G-S.; Amaro R.E.; Computation-guided discovery of influenza endonuclease inhibitors. ACS Med Chem Lett 2014,5(1),61-64","journal-title":"ACS Med Chem Lett"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1016\/j.bmc.2015.07.046","volume":"23","author":"Fudo S.","year":"2015","unstructured":"Fudo S.; Yamamoto N.; Nukaga M.; Odagiri T.; Tashiro M.; Neya S.; Hoshino T.; Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase. Bioorg Med Chem 2015,23(17),5466-5475","journal-title":"Bioorg Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1021\/mp400482a","volume":"11","author":"Carcelli M.","year":"2014","unstructured":"Carcelli M.; Rogolino D.; Bacchi A.; Rispoli G.; Fisicaro E.; Compari C.; Sechi M.; Stevaert A.; Naesens L.; Metal-chelating 2-hydroxyphenyl amide pharmacophore for inhibition of influenza virus endonuclease. Mol Pharm 2014,11(1),304-316","journal-title":"Mol Pharm"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00775-015-1292-0","volume":"20","author":"Rogolino D.","year":"2015","unstructured":"Rogolino D.; Bacchi A.; De Luca L.; Rispoli G.; Sechi M.; Stevaert A.; Naesens L.; Carcelli M.; Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease. J Biol Inorg Chem 2015,20(7),1109-1121","journal-title":"J Biol Inorg Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1021\/acsmedchemlett.5b00109","volume":"6","author":"Pala N.","year":"2015","unstructured":"Pala N.; Stevaert A.; Dallocchio R.; Dess\u00ec A.; Rogolino D.; Carcelli M.; Sanna V.; Sechi M.; Naesens L.; Virtual screening and biological validation of novel influenza virus PA endonuclease inhibitors. ACS Med Chem Lett 2015,6(8),866-871","journal-title":"ACS Med Chem Lett"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1021\/jm020334u","volume":"46","author":"Parkes K.E.","year":"2003","unstructured":"Parkes K.E.; Ermert P.; F\u00e4ssler J.; Ives J.; Martin J.A.; Merrett J.H.; Obrecht D.; Williams G.; Klumpp K.; Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors. J Med Chem 2003,46(7),1153-1164","journal-title":"J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"22880","DOI":"10.1038\/srep22880","volume":"6","author":"Yuan S.","year":"2016","unstructured":"Yuan S.; Chu H.; Singh K.; Zhao H.; Zhang K.; Kao R.Y.; Chow B.K.C.; Zhou J.; Zheng B-J.; A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase. Sci Rep 2016,6,22880","journal-title":"Sci Rep"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1016\/j.bmc.2013.08.053","volume":"21","author":"Parhi A.K.","year":"2013","unstructured":"Parhi A.K.; Xiang A.; Bauman J.D.; Patel D.; Vijayan R.S.; Das K.; Arnold E.; Lavoie E.J.; Phenyl substituted 3-hydroxypyridin-2(1H)-ones: inhibitors of influenza A endonuclease. Bioorg Med Chem 2013,21(21),6435-6446","journal-title":"Bioorg Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1021\/acs.jmedchem.6b00628","volume":"59","author":"Credille C.V.","year":"2016","unstructured":"Credille C.V.; Chen Y.; Cohen S.M.; Fragment-based identification of influenza endonuclease inhibitors. J Med Chem 2016,59(13),6444-6454","journal-title":"J Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1016\/j.bmc.2010.07.017","volume":"18","author":"Vedula M.S.","year":"2010","unstructured":"Vedula M.S.; Jennepalli S.; Aryasomayajula R.; Rondla S.R.; Musku M.R.; Kura R.R.; Bandi P.R.; Novel nucleosides as potent influenza viral inhibitors. Bioorg Med Chem 2010,18(17),6329-6339","journal-title":"Bioorg Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1021\/ml400411e","volume":"4","author":"Abdel-Magid A.F.","year":"2013","unstructured":"Abdel-Magid A.F.; Influenza RNA-dependent RNA polymerase (RdRp) Inhibitors: potential new therapy for influenza treatment. ACS Med Chem Lett 2013,4(12),1133-1134","journal-title":"ACS Med Chem Lett"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.antiviral.2016.01.005","volume":"129","author":"Lin C.","year":"2016","unstructured":"Lin C.; Sun C.; Liu X.; Zhou Y.; Hussain M.; Wan J.; Li M.; Li X.; Jin R.; Tu Z.; Zhang J.; Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents. Antiviral Res 2016,129,13-20","journal-title":"Antiviral Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.antiviral.2011.09.001","volume":"92","author":"Kumaki Y.","year":"2011","unstructured":"Kumaki Y.; Day C.W.; Smee D.F.; Morrey J.D.; Barnard D.L.; In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections. Antiviral Res 2011,92(2),329-340","journal-title":"Antiviral Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"19151","DOI":"10.1073\/pnas.1013592107","volume":"107","author":"Su C.Y.","year":"2010","unstructured":"Su C.Y.; Cheng T.J.R.; Lin M.I.; Wang S.Y.; Huang W.I.; Lin-Chu S.Y.; Chen Y.H.; Wu C.Y.; Lai M.M.C.; Cheng W.C.; Wu Y.T.; Tsai M.D.; Cheng Y.S.; Wong C.H.; High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc Natl Acad Sci USA 2010,107(45),19151-19156","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002668","volume":"8","author":"Ortigoza M.B.","year":"2012","unstructured":"Ortigoza M.B.; Dibben O.; Maamary J.; Martinez-Gil L.; Leyva-Grado V.H.; Abreu P.; Ayllon J.; Palese P.; Shaw M.L.; A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon. PLoS Pathog 2012,8(4)","journal-title":"PLoS Pathog"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/adt.2015.668","volume":"13","author":"Roch F.F.","year":"2015","unstructured":"Roch F.F.; Hinterk\u00f6rner G.; Menke J.; Tang G.Q.; Cusack S.; Butzendobler B.; Buschmann H.; Datta K.; Wolkerstorfer A.; An RNA hybridization assay for screening influenza A virus polymerase inhibitors using the entire ribonucleoprotein complex. Assay Drug Dev Technol 2015,13(8),488-506","journal-title":"Assay Drug Dev Technol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1021\/acs.molpharmaceut.8b00531","volume":"15","author":"Liu T.","year":"2018","unstructured":"Liu T.; Liu M.; Chen F.; Chen F.; Tian Y.; Huang Q.; Liu S.; Yang J.; A small-molecule compound has anti-influenza A virus activity by acting as a \u201cPB2 inhibitor\u201d. Mol Pharm 2018,15(9),4110-4120","journal-title":"Mol Pharm"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.1021\/acs.jmedchem.5b01474","volume":"59","author":"Massari S.","year":"2016","unstructured":"Massari S.; Goracci L.; Desantis J.; Tabarrini O.; Polymerase acidic protein-basic protein 1 (PA-PB1) protein-protein interaction as a target for next-generation anti-influenza therapeutics. J Med Chem 2016,59(17),7699-7718","journal-title":"J Med Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ejmech.2018.08.032","volume":"157","author":"D\u2019Agostino I.","year":"2018","unstructured":"D\u2019Agostino I.; Giacchello I.; Nannetti G.; Fallacara A.L.; Deodato D.; Musumeci F.; Grossi G.; Pal\u00f9 G.; Cau Y.; Trist I.M.; Loregian A.; Schenone S.; Botta M.; Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction. Eur J Med Chem 2018,157,743-758","journal-title":"Eur J Med Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/nature07120","volume":"454","author":"He X.","year":"2008","unstructured":"He X.; Zhou J.; Bartlam M.; Zhang R.; Ma J.; Lou Z.; Li X.; Li J.; Joachimiak A.; Zeng Z.; Ge R.; Rao Z.; Liu Y.; Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus. Nature 2008,454(7208),1123-1126","journal-title":"Nature"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nature07225","volume":"454","author":"Obayashi E.","year":"2008","unstructured":"Obayashi E.; Yoshida H.; Kawai F.; Shibayama N.; Kawaguchi A.; Nagata K.; Tame J.R.H.; Park S-Y.; The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature 2008,454(7208),1127-1131","journal-title":"Nature"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1038\/srep05944","volume":"4","author":"Moen S.O.","year":"2014","unstructured":"Moen S.O.; Abendroth J.; Fairman J.W.; Baydo R.O.; Bullen J.; Kirkwood J.L.; Barnes S.R.; Raymond A.C.; Begley D.W.; Henkel G.; McCormack K.; Tam V.C.; Phan I.; Staker B.L.; Stacy R.; Myler P.J.; Lorimer D.; Edwards T.E.; Structural analysis of H1N1 and H7N9 influenza A virus PA in the absence of PB1. Sci Rep 2014,4,5944","journal-title":"Sci Rep"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1021\/mp900131p","volume":"7","author":"Liu H.","year":"2010","unstructured":"Liu H.; Yao X.; Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation. Mol Pharm 2010,7(1),75-85","journal-title":"Mol Pharm"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"7801","DOI":"10.1128\/JVI.00724-07","volume":"81","author":"Ghanem A.","year":"2007","unstructured":"Ghanem A.; Mayer D.; Chase G.; Tegge W.; Frank R.; Kochs G.; Garc\u00eda-Sastre A.; Schwemmle M.; Peptide-mediated interference with influenza A virus polymerase. J Virol 2007,81(14),7801-7804","journal-title":"J Virol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbagen.2011.11.003","volume":"1820","author":"Fukuoka M.","year":"2012","unstructured":"Fukuoka M.; Minakuchi M.; Kawaguchi A.; Nagata K.; Kamatari Y.O.; Kuwata K.; Structure-based discovery of anti-influenza virus A compounds among medicines. Biochim Biophys Acta 2012,1820(2),90-95","journal-title":"Biochim Biophys Acta"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1128\/AAC.01219-12","volume":"56","author":"Muratore G.","year":"2012","unstructured":"Muratore G.; Mercorelli B.; Goracci L.; Cruciani G.; Digard P.; Pal\u00f9 G.; Loregian A.; Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses. Antimicrob Agents Chemother 2012,56(11),6009-6013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1073\/pnas.1119817109","volume":"109","author":"Muratore G.","year":"2012","unstructured":"Muratore G.; Goracci L.; Mercorelli B.; Foeglein \u00c1.; Digard P.; Cruciani G.; Pal\u00f9 G.; Loregian A.; Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. Proc Natl Acad Sci USA 2012,109(16),6247-6252","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1021\/acs.jmedchem.5b00012","volume":"58","author":"Massari S.","year":"2015","unstructured":"Massari S.; Nannetti G.; Desantis J.; Muratore G.; Sabatini S.; Manfroni G.; Mercorelli B.; Cecchetti V.; Pal\u00f9 G.; Cruciani G.; Loregian A.; Goracci L.; Tabarrini O.; A broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits. J Med Chem 2015,58(9),3830-3842","journal-title":"J Med Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.antiviral.2015.11.005","volume":"125","author":"Yuan S.","year":"2016","unstructured":"Yuan S.; Chu H.; Zhao H.; Zhang K.; Singh K.; Chow B.K.C.; Kao R.Y.T.; Zhou J.; Zheng B.J.; Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase. Antiviral Res 2016,125,34-42","journal-title":"Antiviral Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00705-018-3779-9","volume":"163","author":"Takizawa N.","year":"2018","unstructured":"Takizawa N.; Kimura T.; Watanabe T.; Shibasaki M.; Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis. Arch Virol 2018,163(6),1607-1614","journal-title":"Arch Virol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1016\/j.bmcl.2013.08.048","volume":"23","author":"Kessler U.","year":"2013","unstructured":"Kessler U.; Castagnolo D.; Pagano M.; Deodato D.; Bernardini M.; Pilger B.; Ranadheera C.; Botta M.; Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus. Bioorg Med Chem Lett 2013,23(20),5575-5577","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/cmdc.201300378","volume":"9","author":"Pagano M.","year":"2014","unstructured":"Pagano M.; Castagnolo D.; Bernardini M.; Fallacara A.L.; Laurenzana I.; Deodato D.; Kessler U.; Pilger B.; Stergiou L.; Strunze S.; Tintori C.; Botta M.; The fight against the influenza A virus H1N1: synthesis, molecular modeling, and biological evaluation of benzofurazan derivatives as viral RNA polymerase inhibitors. ChemMedChem 2014,9(1),129-150","journal-title":"ChemMedChem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bmcl.2013.11.019","volume":"24","author":"Tintori C.","year":"2014","unstructured":"Tintori C.; Laurenzana I.; Fallacara A.L.; Kessler U.; Pilger B.; Stergiou L.; Botta M.; High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction. Bioorg Med Chem Lett 2014,24(1),280-282","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1021\/acs.jmedchem.5b01935","volume":"59","author":"Trist I.M.L.","year":"2016","unstructured":"Trist I.M.L.; Nannetti G.; Tintori C.; Fallacara A.L.; Deodato D.; Mercorelli B.; Pal\u00f9 G.; Wijtmans M.; Gospodova T.; Edink E.; Verheij M.; de Esch I.; Viteva L.; Loregian A.; Botta M.; 4,6-Diphenylpyridines as promising novel anti-influenza agents targeting the PA-PB1 protein-protein interaction: structure-activity relationships exploration with the aid of molecular modeling. J Med Chem 2016,59(6),2688-2703","journal-title":"J Med Chem"},{"key":"ref=112","unstructured":"Regional Office for Europe Pandemic influenza World Heath OrganizationAvailable at:\npandemic-influenza (Accessed on Feb 13, 2019).","journal-title":"Regional Office for Europe Pandemic influenza"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature14009","volume":"516","author":"Reich S.","year":"2014","unstructured":"Reich S.; Guilligay D.; Pflug A.; Malet H.; Berger I.; Cr\u00e9pin T.; Hart D.; Lunardi T.; Nanao M.; Ruigrok R.W.H.; Cusack S.; Structural insight into Cap-snatching and RNA synthesis by influenza polymerase. Nature 2014,516(7531),361-366","journal-title":"Nature"},{"key":"ref=114","unstructured":"RCSB Protein Data Bank4WSB (Accessed on Nov 17, 2020) https:\/\/www.rcsb.org\/structure\/"},{"key":"ref=115","unstructured":"Schr\u00f6dinger Pymol:(Accessed on Nov 17, 2020). https:\/\/pymol.org\/2\/"},{"key":"ref=116","unstructured":"RCSB Protein Data Bank6FS6 (Accessed on Nov 17, 2020) https:\/\/www.rcsb.org\/structure\/"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1093\/bioinformatics\/bty419","volume":"34","author":"Rose A.S.","year":"2018","unstructured":"Rose A.S.; Bradley A.R.; Valasatava Y.; Duarte J.M.; Prlic A.; Rose P.W.; NGL Viewer: Web-based molecular graphics for large complexes. Bioinformatics 2018,34(21),3755-3758","journal-title":"Bioinformatics"},{"key":"ref=118","unstructured":"RCSB Protein Data Bank4AWM (Accessed on Nov 17, 2020). https:\/\/www.rcsb.org\/structure\/"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200114115632","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/178298\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200114115632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T18:30:45Z","timestamp":1660069845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178298\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":118,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327666200114115632","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}